Scientific News Boston Scientific S Swot Analysis Medtech Giant S Stock Poised For Growth
Search Related Content
Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific S Swot Analysis Medtech Giant S Stock Poised For Growth is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific: Premium MedTech Growth Story With Attractive Valuation Upside
Boston Scientific is a Buy with a $109 target and 14% upside from strong demand, Q3 beats, raised FY25 guidance, and growth leadership. See why BSX stock is a buy. Read More
Boston Scientific rises as cardiology sales drive Q3 beat, guidance boost
Boston Scientific (NYSE:BSX) traded higher on Wednesday after the MedTech giant exceeded Street forecasts with its Q3 2025 results and boosted its full-year outlook following better-than-expected ... Read More
The 10 most-read medtech news stories of 2025
Significant changes at Johnson & Johnson were among the most-read medtech news on MassDevice over the past year. Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus